LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

Search

Globus Medical Inc (Class A)

Закрыт

СекторЗдравоохранение

87.98 0.98

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

87

Макс.

89.79

Ключевые показатели

By Trading Economics

Доход

-84M

119M

Продажи

24M

769M

P/E

Средняя по отрасли

28.346

121.746

Прибыль на акцию

1.18

Рентабельность продаж

15.469

Сотрудники

5,300

EBITDA

22M

215M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+21.59% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

24 февр. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

3.6B

12B

Предыдущая цена открытия

87

Предыдущая цена закрытия

87.98

Новостные настроения

By Acuity

17%

83%

22 / 352 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Globus Medical Inc (Class A) График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

12 февр. 2026 г., 23:57 UTC

Популярные акции

Stocks to Watch: Applied Materials, Arista, DraftKings, Pinterest

12 февр. 2026 г., 23:35 UTC

Отчет
Главные движущие силы рынка

Arista Networks Surges on AI Networking Demand, Despite Rising Costs

12 февр. 2026 г., 23:28 UTC

Отчет

Applied Materials Profit Rises on Soaring AI Demand -- Update

12 февр. 2026 г., 21:47 UTC

Отчет

Vertex Pharmaceuticals Revenue Climbs on Continued Cystic Fibrosis Demand

13 февр. 2026 г., 00:00 UTC

Обсуждения рынка

ANZ Gets a New Bull as Productivity Prospects Improve -- Market Talk

12 февр. 2026 г., 23:47 UTC

Обсуждения рынка

Nikkei May Fall After AI Concerns Drag Stocks on Wall Street -- Market Talk

12 февр. 2026 г., 23:38 UTC

Обсуждения рынка

Gold Steady; Could Undergo Technical Recovery -- Market Talk

12 февр. 2026 г., 23:33 UTC

Отчет

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- 2nd Update

12 февр. 2026 г., 23:09 UTC

Обсуждения рынка

South32's Hermosa Review Stokes Spending Fears -- Market Talk

12 февр. 2026 г., 22:55 UTC

Отчет
Популярные акции

Applied Materials, DraftKings, Airbnb: Earnings in Focus -- WSJ

12 февр. 2026 г., 22:46 UTC

Обсуждения рынка

Northern Star Outlook Needs Project Done On Time, In Budget -- Market Talk

12 февр. 2026 г., 22:23 UTC

Отчет

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- Update

12 февр. 2026 г., 22:15 UTC

Отчет

Agnico-Eagle Mines: Gold Production for 2026 and 2027, Expected at 3.3M to 3.5M Ounces Annually, Is Consistent With Previous Guidance, With Offsetting Adjustments Between Mine Sites >AEM.T

12 февр. 2026 г., 22:15 UTC

Отчет

Agnico-Eagle Mines Raises Dividend to 45c >AEM.T

12 февр. 2026 г., 22:15 UTC

Отчет

Agnico-Eagle Mines 4Q Rev $3.56B >AEM.T

12 февр. 2026 г., 22:15 UTC

Отчет

Agnico-Eagle Mines 4Q EPS $3.04 >AEM.T

12 февр. 2026 г., 22:00 UTC

Отчет

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12 февр. 2026 г., 22:00 UTC

Отчет

Agnico-Eagle Mines 4Q Rev $3.56B >AEM

12 февр. 2026 г., 22:00 UTC

Отчет

Agnico-Eagle Mines 4Q Net $1.52B >AEM

12 февр. 2026 г., 22:00 UTC

Отчет

Agnico-Eagle Mines 4Q Adj EPS $2.70 >AEM

12 февр. 2026 г., 22:00 UTC

Отчет

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12 февр. 2026 г., 22:00 UTC

Отчет

Agnico-Eagle Mines 4Q EPS $3.04 >AEM

12 февр. 2026 г., 21:57 UTC

Отчет

XP 4Q Rev BRL4.95B >XP

12 февр. 2026 г., 21:52 UTC

Отчет

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12 февр. 2026 г., 21:50 UTC

Обсуждения рынка

Tech, Media & Telecom Roundup: Market Talk

12 февр. 2026 г., 21:50 UTC

Обсуждения рынка

Financial Services Roundup: Market Talk

12 февр. 2026 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

12 февр. 2026 г., 21:47 UTC

Отчет

Morningstar 4Q Rev $641M >MORN

12 февр. 2026 г., 21:39 UTC

Отчет

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12 февр. 2026 г., 21:38 UTC

Отчет

Howmet Stock Jumps. Earnings Show Strength For This Sector. -- Barrons.com

Сравнение c конкурентами

Изменение цены

Globus Medical Inc (Class A) Прогноз

Целевая цена

By TipRanks

21.59% рост

Прогноз на 12 месяцев

Средняя 106.5 USD  21.59%

Максимум 118 USD

Минимум 87 USD

Основано на мнении 14 аналитиков Wall Street, спрогнозировавших целевые цены для Globus Medical Inc (Class A) на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

14 ratings

11

Покупка

3

Удержание

0

Продажа

Техническая оценка

By Trading Central

72.18 / 73.07Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bearish Evidence

Долгосрочная

Weak Bearish Evidence

Настроения

By Acuity

22 / 352Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat